Literature DB >> 28753207

The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Katherine Baran1, Mao Yang1, Christopher P Dillon1, Leona L Samson2, Douglas R Green1.   

Abstract

In addition to promoting cell death and senescence, p53 also has important cellular survival functions. A mutant p53, lacking a proline-rich domain (p53ΔP), that is deficient in controlling both cell death and cell cycle arrest, was employed to determine the biological means by which p53 mediates survival upon DNA damage. While p53ΔP and p53-/- cells were equally resistant to many DNA damaging agents, p53ΔP cells showed an exquisite resistance to high doses of the alkylating agent Diazald (N-Methyl-N-(p-tolylsulfonyl)nitrosamide), as compared to cells completely deficient for p53 function. We determined that p53ΔP was capable of transcribing the repair gene, MGMT (O6-methylguanine-DNA methyltransferase) after irradiation or alkylation damage, resulting in DNA repair and cell survival. Consistent with these observations, p53ΔP mice show enhanced survival after IR relative to p53-/- mice. Suppression or deletion of MGMT expression in p53ΔP cells inhibited DNA repair and survival after alkylation damage, whereas MGMT overexpression in p53-deficient cells facilitated DNA repair and conferred survival advantage. This study shows that when cell death and cell cycle arrest pathways are inhibited, p53 can still mediate MGMT-dependent repair, to promote cell survival upon DNA damage.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28753207      PMCID: PMC5635218          DOI: 10.1038/cdd.2017.116

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  64 in total

1.  High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase.

Authors:  T Iwakuma; K Sakumi; Y Nakatsuru; H Kawate; H Igarashi; A Shiraishi; T Tsuzuki; T Ishikawa; M Sekiguchi
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

2.  Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

Authors:  Jerry E Chipuk; Ulrich Maurer; Douglas R Green; Martin Schuler
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

3.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

4.  Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.

Authors:  Gerburg M Wulf; Yih-Cherng Liou; Akihide Ryo; Sam W Lee; Kun Ping Lu
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

5.  Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD).

Authors:  H G Campbell; R Mehta; A A Neumann; C Rubio; M Baird; T L Slatter; A W Braithwaite
Journal:  Oncogene       Date:  2012-04-09       Impact factor: 9.867

6.  p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents.

Authors:  T Grombacher; U Eichhorn; B Kaina
Journal:  Oncogene       Date:  1998-08-20       Impact factor: 9.867

Review 7.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Harinder Garewal
Journal:  Mutat Res       Date:  2002-06       Impact factor: 2.433

8.  Inability of Chinese hamster ovary cells to excise O6-alkylguanine.

Authors:  R Goth-Goldstein
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

9.  Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.

Authors:  Takeshi Nagasaka; Ajay Goel; Kenji Notohara; Takaomi Takahata; Hiromi Sasamoto; Takuyuki Uchida; Naoshi Nishida; Noriaki Tanaka; Clement Richard Boland; Nagahide Matsubara
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

Review 10.  DNA repair, genome stability and cancer: a historical perspective.

Authors:  Penny A Jeggo; Laurence H Pearl; Antony M Carr
Journal:  Nat Rev Cancer       Date:  2015-12-15       Impact factor: 60.716

View more
  2 in total

1.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

2.  ZNF185 is a p53 target gene following DNA damage.

Authors:  Artem Smirnov; Angela Cappello; Anna Maria Lena; Lucia Anemona; Alessandro Mauriello; Nicola Di Daniele; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Eleonora Candi
Journal:  Aging (Albany NY)       Date:  2018-11-16       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.